Posted: October 20, 2014 at 4:40 pm
Understanding Niche Cells | Science: Out of the Box
Johns Hopkins cell biologist Erika Matunis explains how understanding the cells that take care of stem cells may shed light on cancer. To see more Science: Out of the Box videos, visit http://www...
By: Johns Hopkins Medicine
Continued here:
Understanding Niche Cells | Science: Out of the Box - Video
Posted: October 20, 2014 at 4:40 pm
TWIS Minion / Science Island Hangout October 16, 2014
Amy Lynn Thompson, Ed Dyer, AJ Smith and Dale Liebrecht talking about Mars missions, the Milky Way being a bully, Black Holes, the mighty stem cells healing hearts and eyes and more. Show...
By: Edward Dyer
Visit link:
TWIS Minion / Science Island Hangout October 16, 2014 - Video
Posted: October 20, 2014 at 4:40 pm
Dr Nathan Newman explains Stem Cells
Dr. Nathan Newman explains how adult stem cells are revolutionizing medicine and how they #39;re already being used in treatment of cosmetic and reconstructive to rejuvenate damaged tissues and...
By: Yingyao
Read more here:
Dr Nathan Newman explains Stem Cells - Video
Posted: October 20, 2014 at 4:40 pm
Can Stem Cell Injections Cure Blindness?
Stem cells may be able to cure blindness through injecting them into the eyes of people who are blind. The procedure worked over a three year period in restoring the vision of eighteen patients...
By: TheLipTV
Posted: October 20, 2014 at 4:40 pm
The Stem Cell #39;s Journey
DescriptionStem cells have the ability to transform into many different cell types, but Stemmy the stem cell possesses a unique gift: he can transform cells around him into duplicates of himself....
By: Jeff Alu
The rest is here:
The Stem Cell's Journey - Video
Posted: October 20, 2014 at 4:40 pm
Stem Cell Research | Trichology | Hair Restoration Dallas
As Dallas #39;s premiere Hair Restoration Center, we are very excited about the new possibilities of using Stem Cells, to treat Hair Loss and Baldness.
By: KeyElementMedia
See the article here:
Stem Cell Research | Trichology | Hair Restoration Dallas - Video
Posted: October 20, 2014 at 4:40 pm
Stem cell Research for Paralysis
Website - http://www.drdassans.com Contact Us - +91-7355793557, +0181-5040006. Email: drdassans@gmail.com enquiry@drdassans.com.
By: Dr Dassan #39;s Ayurvedic Herbal Formulations
Follow this link:
Stem cell Research for Paralysis - Video
Posted: October 20, 2014 at 12:00 pm
Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.
SOURCE Reportlinker
NEW YORK, Oct. 13, 2014 /PRNewswire/ -- The key to Transforming Future of Diagnostic and Therapeutic Medicine
This study investigates the global stem cell market for the period 2013 to 2018. The geographic regions covered in the study are the North America, Europe and APAC, followed by a detailed Asia Pacific Region Analysis, which covers countries such as India, Australia, Thailand, Singapore, South Korea, Malaysia and Japan. The stem cell market is covered into four broad segments, namely by products, by technology and by application. The study covers various areas of interest such as regulatory policies within stem cell research, key business updates, analysis of risk factors, and strategic recommendations. Additionally, key clinical milestones, timelines of key clinical events, key companies to watch, and a strategic partnership assessment in the global stem cell market have been included.
Key Findings -The global market for stem cell was $ billion in 2013 and is expected to reach $ billion in 2018, growing at a robust CAGR of% from 2013 to 2018. -The worldwide market for adult stem cell is estimated to be at $billion in 2013 and is projected to reach $ billion by 2018. Adult stem cells constitute % of the total stem cell market. -Cord blood banking is one of the fastest growing segments of the stem cell market. The number of active cord blood banks worldwide have grown from mere in 2005 to over in 2013. -North America's total stem cell market was valued at $ billion in 2013 and is projected to increase to $ billion by 2018. -The European stem cell market was valued at $billion in 2013 and is projected to increase to $billion by 2018. -The Asia-Pacific (APAC) stem cell market was valued at $ billion in 2013 and is projected to increase to $billion by 2018. -APAC countries are progressing fast in the field of various stem cells research, including human embryonic stem cells, induced pluripotent stem cell (IPSc) and others. The major hurdle has been the regulatory environment in these countries, but that has been changing lately. Several Asian countries have modified their regulations regarding stem cell research to attract more investors. -India, Singapore and South Korea are the frontrunners and are expected to dominate the APAC stem cells market in the coming years. Favourable regulatory changes and funding support from governments have helped the commercialization of the stem cells industry. -Indian stem cell market was estimated to be $ million in 2013 and is expected to grow at a CAGR of % from 2013 to 2018. -Current penetration of stem cell banking in Singapore is % and is expected to grow at a CAGR of % in next years. -South Korea is all set to lead the stem cell research in APAC. Funding in stem cell in this country could be compared to that of US. -Stem cells obtained from adult organisms constitute the main focus of research and the ethics surrounding the use of these cells are quite undisputed. Therapies employing adult stem cells are being developed by various companies (such as ViaCell, StemSource, Osiris Therapeutics, Neural Stem, and Angioblast) and are moving fast from laboratory to the clinical application phase. -Majority of companies pursuing stem cell therapeutics are engaged in the development of adult stem cells derived from sources such as bone marrow, neural tissue, adipose tissue, menstrual blood, and placenta.
Read the full report: http://www.reportlinker.com/p02414037-summary/view-report.html
About Reportlinker ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________ Contact Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001
2012 PR Newswire. All Rights Reserved.
Continued here:
Analysis of the Global Stem Cell Market - wistv.com ...
Posted: October 20, 2014 at 11:59 am
Researchers have grown a miniature human intestine in laboratory mice for the first time as part of a research project, which claims to one day be able to cure intestinal diseases by using a patient's own tissue cells.
In a study published in Nature Medicine, researchers from Cincinnati Children's Hospital Medical Centre in the US state of Ohio said that this method "provides a new way to study the many diseases and conditions that can cause intestinal failure, from genetic disorders appearing at birth to conditions that strike later in life, such as cancer and Crohn's disease."
In the first step, stem cells were bioengineered to grow "organoids" of functioning human intestinal tissues from pluripotent stem cells. These were transplanted into the mouse's kidney capsule, which was given a blood supply.
The mice in question were also genetically engineered in order to prevent the risk of their immune systems rejecting the implanted human tissue.
Six to eight weeks after the transplantation, the ball of cells had already grown larger than a regular mouse kidney. The researchers noted that they had replicated almost all of the tissue variations normally found within a human intestine, and that these were capable of digesting and absorbing food.
According to the researchers, this procedure has created a new model for studying intestinal disorders and diseases. As, while this latest research grows human organs from scratch, it also supports the idea that whole organs, built from complex arrangements of tissues, can be generated within the patient's body.
Researchers noted in the paper that studies carried out on animals often do not produce the same results in people. Yet they suggest that this research may offer alternatives to animal testing in the future, as well as produce better laboratory models of diseased tissues for drugs testing, and speed up the development of new medicines and treatments.
"These studies support the concept that patient-specific cells can be used to grow intestines," said Michael Helmrath, who led the study, adding that the research "advanced the longer-term aim of growing tissues that can replace damaged human intestine."
An advantage of using the patient's own tissues in the treatment process is that it eliminates both the risk of transplant rejection, and the expense of needing to take life-long drugs to prevent this rejection.
While this latest research represents a step forward in terms of stem cell and organoid research at the Cincinnati Children's Hospital, researchers added that it could still take several years before lab grown tissue replacements are incorporated into medical practices.
See the original post here:
Miniature human intestine grown in mice for first time
Posted: October 20, 2014 at 11:56 am
The identification of stem cells as "embryonic" and "adult" refer to their origin.
Embryonic Stem Cells are found within the human embryo at the blastocyst stage (7-14 days after fertilization). They are pluripotent stem cells. These embryonic stem cells are amazing because they will multiply and differentiate to make up every cell of the human body, from those in the blood to those in the bone. It is truly a testament to the beauty of life that these simple looking cells can create the entire structure of the human body.
Adult stem cells can be found in many places within the human body. It can be found in bone marrow, umbilical cord blood, placenta, brain, skeletal muscle, hair follicales, fat, and many others places. Up until recently, adult stem cells were always referred to as multipotent stem cells, that is, they could only differentiate into the tissue cells of their origin tissue. Because of this, proponents of embryonic stem cell research look down upon adult stem cells because of their "limited" characteristics. However, as recent studies have confirmed, scientists have begun to unlocked the pluripotency of adult stem cells.
These adult stem cells are isolated from the patient, multiplied in the lab, directed towards the cell needed, and inserted at the place where tissue needs to be repaired or replaced. Because these stem cells are original to the host, there is no rejection by the immune system. Because they are retrieved from a certain type of tissue, there is no threat of multiplication in teratomas.
